2nd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for CENTRIENT PHARMACEUTICALS LLC

Firm
Client
Income
$140,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Advocacy regarding solutions for onshore supply chain and manufacturing of critical medicines back to the United States.

LobbyistCovered position, as disclosed
DANIEL GRAVER —

Contacted: Natl Security Council (NSC); Natl Economic Council (NEC); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Advocacy regarding solutions for onshore supply chain and manufacturing of critical medicines back to the United States.

LobbyistCovered position, as disclosed
ANNA ABRAM New Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06
HEIDE BAJNRAUH —
SEAN FEELY New —
DANIEL GRAVER —
MATTHEW HITTLE —
GEOFF VERHOFF —

Contacted: Natl Security Council (NSC); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); SENATE

Pharmacy PHA

Advocacy regarding solutions for onshore supply chain and manufacturing of critical medicines back to the United States.

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH —
SEAN FEELY New —
DANIEL GRAVER —
MATTHEW HITTLE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Natl Security Council (NSC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.